An information platform for unlisted & pre-IPO sharesNot a SEBI-recognised stock exchange or trading platformAll prices are indicative
UnlistedZone
← PharmEasy · News

PharmEasy news & insights

Every article we've published on PharmEasy — results, funding rounds, IPO plans and market commentary. Information only, not advice.

Detailed Blog Post: Navigating the Complex Landscape of Pharmeasy's INR 3500 Cr Right Issue of CCPS B
28 Sept 2023 · News

Detailed Blog Post: Navigating the Complex Landscape of Pharmeasy's INR 3500 Cr Right Issue of CCPS B

Introduction Pharmeasy, a significant player in India's digital pharmacy landscape, has recently announced its plan to raise INR 3500 Cr through a Rig…

1,419 viewsRead →
Analysis of Pharmeasy FY23 and Q1Fy24 Financials
23 Aug 2023 · News

Analysis of Pharmeasy FY23 and Q1Fy24 Financials

1. Steps taken to improve Profitability by Pharmeasy in Fy23 a) Marketing and growth expenses are reduced as a % of revenue from 7.9% in FY’22 t…

1,774 viewsRead →
Pharmeasy's Debt Retirement and Funding Options: UnlistedZone Analysis
06 Jul 2023 · News

Pharmeasy's Debt Retirement and Funding Options: UnlistedZone Analysis

Introduction In recent news, it has been reported that Pharmeasy, a leading online pharmacy in India, is looking to retire its substantial debt of ₹2,…

112 viewsRead →
API Holdings Set To Demerge Mahaveer Medicos Under Ascent Wellness And Pharma
27 Jun 2023 · News

API Holdings Set To Demerge Mahaveer Medicos Under Ascent Wellness And Pharma

API Holdings Announces a Strategic Business Meeting API Holdings is scheduled to hold an important strategic business meeting via video conferencing o…

303 viewsRead →
PharmEasy Appoints Avendus Capital for Equity Funding
12 Jun 2023 · News

PharmEasy Appoints Avendus Capital for Equity Funding

Introduction: PharmEasy, a prominent online pharmacy platform, has recently announced its partnership with Avendus Capital to raise equity funding. Th…

211 viewsRead →
PharmEasy mails health ministry for quick draft rules notification.
24 May 2023 · News

PharmEasy mails health ministry for quick draft rules notification.

1. API Holdings, the parent company of PharmEasy, has requested the Union Health Minister, Mansukha Mandaviya, to expedite the notification of draft e…

123 viewsRead →
Janus Henderson Marks Down Pharmeasy's Valuation by Half to $2.8Bn
15 May 2023 · News

Janus Henderson Marks Down Pharmeasy's Valuation by Half to $2.8Bn

Global Investors Mark Down PharmEasy Valuation Amid Financial Struggles and Broader Tech Downturn 1. Markdown in PharmEasy's Valuation: According to r…

140 viewsRead →
Excerpts from the Interview of Co-founder of Pharmeasy with Times Now.
19 Oct 2022 · News

Excerpts from the Interview of Co-founder of Pharmeasy with Times Now.

Ques. Why have you decided to not go ahead with the IPO? I think there are a couple of factors first and foremost, I think the companies on a very dif…

303 viewsRead →
Pharmeasy Right Issue at Rs.100 opening from 21.09.2022. Should You Apply?
22 Sept 2022 · News

Pharmeasy Right Issue at Rs.100 opening from 21.09.2022. Should You Apply?

Basic Details API holding, the parent company of Pharmeasy, is going to conduct the rights issue to raise funds and strengthen the valuation of the co…

255 viewsRead →
Pharmeasy parent API Holdings filed DRHP for Rs 6250 crore IPO
11 Nov 2021 · News

Pharmeasy parent API Holdings filed DRHP for Rs 6250 crore IPO

PharmEasy, a leading name in India's e-pharmacy sector, has recently made a significant move towards its growth trajectory by filing for an Initial Pu…

458 viewsRead →
On the go

Your watchlist, in the UnlistedZone app.

Indicative prices, company research and your enquiries — in your pocket. Get price notes on the names you follow and reach our team from anywhere.

265+
Shares tracked
Get it on Google PlayDownload on the App Store
Today’s indicative prices
MSMetropolitan Stock Exchange (MSEI) Unlisted Shares₹6.75
HPHindustan Power Exchange Limited (HPX India)₹23.5
OROnix Renewable Limited₹41
GEGFCL EV Products Limited₹38.5
Enquire to buy